Written by Stuart Stevens | Thursday, 07 September 2006
The maker of the lesser known erectile dysfunction medication Levitra has unveiled a rise in profits for 2nd quarter earnings this year. The German pharma giant Bayer AG announced an 11% increase the 2nd quarter profit due to the growing sales of its vast array of drugs but noted that Levitra's strong sales played a part in boosting revenue. The sales of Levitra this year have increased the profits of the Bayer Healthcare division and in fact the figures showed a 16% growth in the sales of Levitra rising up to 73 million Euros.
Of the three impotence drugs Viagra, Cialis and Levitra it is Levitra that is the least known about. It came on to the market when Viagra was already and a household name and Cialis had had a good headstart. Like the other 2 it works as a PDE-5 inhibitor and is the preferred erectile dysfunction medication of some men. Its key ingredient is vardenafil and works just like tadalafil and sildenafil (that are found in Cialis and Viagra respectively) by expanding the penile artery that is so important for good sexual function and a hard erection.
Levitra has had some noticeable successes with its marketing, stealing market share from both Viagra and Cialis and being the least known of the three has had to fight the hardest for each percentage point. It is famous for having used Jerry Halll, the one time husband of rocker Mick Jagger as an ambassador and a front for the drug which won it much publicity.
Ukmedix notes that almost everyone has heard of Viagra, quite a few know about Cialis but far less have heard of the drug Levitra.